Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
Frequently Asked Questions
What is Market Cap of Interleukin Genetics, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Interleukin Genetics, Inc. market cap is N/A.
What is the 52-week high for Interleukin Genetics, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Interleukin Genetics, Inc. 52 week high is N/A as of September 12, 2025.
What is the 52-week low for Interleukin Genetics, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Interleukin Genetics, Inc. 52 week low is N/A as of September 12, 2025.
What is Interleukin Genetics, Inc. stock price today?
Interleukin Genetics, Inc. stock price today is $0.0045.
What was Interleukin Genetics, Inc. stock price yesterday?
Interleukin Genetics, Inc. stock price yesterday was $0.0035.
What is the PE ratio of Interleukin Genetics, Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Interleukin Genetics, Inc.’s P/E ratio is None.
What is the Price-to-Book ratio of Interleukin Genetics, Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Interleukin Genetics, Inc. P/B ratio is None.
What is Interleukin Genetics, Inc.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Interleukin Genetics, Inc.'s EBITDA is N/A.
What is the 50-day moving average of Interleukin Genetics, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Interleukin Genetics, Inc. 50-day moving average is N/A.
How many employess does Interleukin Genetics, Inc. has?